Content about STATION

May 16, 2013
Coppertone encourages parents to protect children from UV rays year-round

Merck Consumer Care, the makers of Coppertone, launched today the "Making the Sunscreen Grade" program to equip parents with tools to help their children develop lifelong sun habits.

May 8, 2013
Merck submits FDA filing for ragweed allergy drug

Drug maker Merck is seeking regulatory approval for an experimental tablet placed under the tongue that could be used to treat ragweed allergies.

May 6, 2013
FDA approves Merck cholesterol drug

The Food and Drug Administration has approved a new drug made by Merck for treating high cholesterol, the drug maker said.

March 8, 2013
Leticia Moreinos Schwartz to promote Type 2 diabetes awareness among Hispanics

Drug maker Merck has hired celebrity chef and cookbook author Leticia Moreinos Schwartz as a spokeswoman to reach out to Hispanics living with Type 2 diabetes, the drug maker said.

January 25, 2013
Merck: FDA approves Oxytrol for Women, creating overactive bladder category in OTC

Merck on Friday announced the Food and Drug Administration has approved the switch of Oxytrol for Women (oxybutynin transdermal system, 3.9 mg/day) from prescription-only to nonprescription, creating a new category — overactive bladder in women — in the OTC area.

December 3, 2012
Merck starts Alzheimer's drug trial

Merck has started a clinical trial that it hopes will eventually enroll 1,700 patients to evaluate an experimental drug for Alzheimer's disease, the company said.

November 8, 2012
FDA accepts Merck application for insomnia drug

The Food and Drug Administration has accepted an application from Merck for an experimental drug for insomnia, the drug maker said Thursday.

September 10, 2012
Patients who stop taking insomnia drug continue having sleeping problems, Merck study finds

A study of an experimental drug for insomnia indicated that patients who stop taking it continue having sleeping problems, according to results of a clinical trial announced Monday.

April 30, 2012
Merck wins patent infringement suits against Mylan

Mylan will be barred from marketing a generic version of a Merck cardiovascular drug until the drug's patent expires, under a court ruling announced Friday.

April 16, 2012
Merck, Endocyte sign deal to develop cancer drug

Two drug makers have signed a deal to develop an experimental drug for treating two types of cancer.

March 6, 2012
FDA declines to approve Merck cholesterol drug

The Food and Drug Administration is asking for additional data before it approves a new cholesterol drug made by Merck, the drug maker said.

February 7, 2012
Investigational Merck drug 'significantly' reduces cardiovascular death

A drug under development by Merck "significantly" reduced the risk of heart attack, stroke and cardiovascular death in patients, according to clinical trial results announced Tuesday.

February 2, 2012
FDA approves Merck diabetes drug

The Food and Drug Administration has approved a drug made by Merck for Type 2 diabetes, the drug maker said Thursday.

October 6, 2011
Merck chairman announces retirement

Merck chairman Richard Clark is retiring, the company said Thursday.

October 5, 2011
FDA to review Merck, Ariad drug for bone, soft-tissue sarcomas

The Food and Drug Administration has accepted a regulatory approval application from Merck and Ariad Pharmaceuticals for a new drug to treat soft-tissue and bone cancers, the drug makers said Wednesday.

July 29, 2011
Merck announces plans to trim workforce

Merck disclosed plans to reduce its workforce by 12% to 13% by the end of 2015, the company announced Friday in its second-quarter earnings release.

July 14, 2011
Merck partners with universities to research ways to eradicate HIV

A team comprised of scientists from drug maker Merck and several U.S. universities will look for ways to eradicate HIV, Merck said.

June 13, 2011
Merck, Hanwha to develop Enbrel biosimilar

Merck will collaborate with a Korean manufacturer to develop a biosimilar version of a drug used for autoimmune diseases.

May 16, 2011
Merck closes Inspire acquisition

Drug maker Merck has completed its acquisition of eye care company Inspire.

May 9, 2011
Merck kicks off Hope Against Hepatitis C initiative

Drug maker Merck announced that it has kicked off an initiative that includes a wide range of public education and patient support programs, as well as research efforts to help improve care for people living with chronic hepatitis C virus infections.

April 28, 2011
Merck closer to acquiring Inspire

Merck has cleared a hurdle in its effort to buy eye care company Inspire Pharmaceuticals for $430 million, the company said Thursday.

April 21, 2011
Merck, Sanofi commence late-stage trial for childhood diseases vaccine

Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

April 12, 2011
Sylatron OKed as add-on melanoma treatment

The Food and Drug Administration has approved a treatment made by Merck for treating skin cancer, Merck said Monday.

April 5, 2011
Merck eyes Inspire

Drug maker Merck is looking to boost its eye care portfolio by acquiring a company focused on developing and commercializing ophthalmic products. The deal carries a cash value of about $430 million.

March 9, 2011
Merck seeks FDA approval for Saflutan

The Food and Drug Administration has accepted an approval application from Merck for a drug to treat eye diseases, Merck said Wednesday.

© 2013 Drug Store News. All Rights Reserved.